EMEA-000006-PIP02-10
Key facts
| Invented name |
Inegy and associated names
|
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/95/2011
|
| PIP number |
EMEA-000006-PIP02-10
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Prevention of cardiovascular events in chronic kidney disease
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Merck Sharp & Dohme Limited
E-mail: regaffairseurope@organon.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|